Search - tctmd.com

Displaying 21 - 40 of 74

Sort: Relevancy | Date

News Daily News

Meta 分析证实了第二代 DES 的晚期安全性

L.A. McKeown

June 10, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Daily News

含可生物降解聚合物的 DES 可安全使用、耐用长达 5 年

L.A. McKeown

January 28, 2015

News Daily News

Los SLF con Polímero Biodegradable son Seguros y Duraderos al cabo de 5 Años

L.A. McKeown

January 28, 2015

News Daily News

DES With Biodegradable Polymer Safe, Durable Through 5 Years

L.A. McKeown

January 28, 2015

Presentation

Five-Year Clinical Outcome of the Nobori DES in the Treatment of Patients With CAD

Presenter: Bernard Chevalier

January 12, 2015

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Daily News

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

Yael L. Maxwell

November 17, 2014

News Daily News

SECURITY: 6 Meses de Terapia Antiplaquetaria Doble No son Inferiores a 12 Meses en Pacientes de Bajo Riesgo Post-PCI

Yael L. Maxwell

November 17, 2014

News Daily News

SECURITY：在PCI后的低风险患者中，6个月DAPT相对于12个月的该策略具有非劣效性

Yael L. Maxwell

November 17, 2014

News Daily News

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Salynn Boyles

November 02, 2014

News Daily News

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

Salynn Boyles

November 02, 2014

News Daily News

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

Salynn Boyles

November 02, 2014

Presentation TCT 2014

Safety and Efficacy Profile of BioMatrix and Nobori in Simple and Complex Lesions: Global Program Overview

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker

September 15, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

News Conference News TCT 2014

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

September 14, 2014

News Conference News TCT 2014

CTO-IVUS Trial Supports IVUS Guidance for CTO PCI

September 14, 2014

News Conference News TCT 2014

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

September 14, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

Advertisement

Meta 分析证实了第二代 DES 的晚期安全性

Trials Explore the Potential of Biodegradable-Polymer Stents

含可生物降解聚合物的 DES 可安全使用、耐用长达 5 年

Los SLF con Polímero Biodegradable son Seguros y Duraderos al cabo de 5 Años

DES With Biodegradable Polymer Safe, Durable Through 5 Years

Five-Year Clinical Outcome of the Nobori DES in the Treatment of Patients With CAD

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

SECURITY: 6 Meses de Terapia Antiplaquetaria Doble No son Inferiores a 12 Meses en Pacientes de Bajo Riesgo Post-PCI

SECURITY：在PCI后的低风险患者中，6个月DAPT相对于12个月的该策略具有非劣效性

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

Safety and Efficacy Profile of BioMatrix and Nobori in Simple and Complex Lesions: Global Program Overview

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

CTO-IVUS Trial Supports IVUS Guidance for CTO PCI

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

COMPARE II: BES, EES Show Similar Outcomes at Three Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content